✦ LIBER ✦

3D QSAR STUDIES OF INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR [EGFR] USING CoMFA AND GFA METHODOLOGIES

✍ Scribed by Deepa V. Pednekar; Mandar A. Kelkar; Surekha R. Pimple; Krishnacharya G. Akamanchi

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 734 KB
Volume: 13
Category: Article
ISSN: 1054-2523
DOI: 10.1007/s00044-004-0105-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3D QSAR STUDIES OF INHIBITORS OF CHOLEST

3D QSAR STUDIES OF INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) BY CoMFA, CoMSIA AND GFA METHODOLOGIES

✍ Mandar A. Kelkar; Deepa V. Pednekar; Surekha R. Pimple; Krishnacharya G. Akamanc 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 681 KB

New Potent 5-Nitrofuryl Derivatives as I

New Potent 5-Nitrofuryl Derivatives as Inhibitors of Trypanosoma cruzi Growth. 3D-QSAR (CoMFA) Studies.

✍ Gabriela Aguirre; Mariana Boiani; Eliana Cabrera; Hugo Cerecetto; Rossanna Di Ma 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): Simple drugs with a complex mechanism of action?

✍ Nicola Normanno; Monica R. Maiello; Antonella De Luca 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

## Abstract A range of target‐based agents for the treatment of solid tumors are in development. The epidermal growth factor receptor (EGFR) has been identified as a relevant target as it is involved in regulating several cellular functions important in the proliferation and survival of cancer cell

ChemInform Abstract: 6-Substituted-4-(3-

ChemInform Abstract: 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity.

✍ Hwei-Ru Tsou; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

Differential sensitivities of trastuzuma

Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors

✍ Carmel T. Chan; Marianne Z. Metz; Susan E. Kane 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 580 KB

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views